Vaccine trials are not expensive..Who told you that. Getting a drug to market is expensive. Vaccines are needles in arms and not long term daily doses of a drug or placebo.
Good thoughts, but the FDA will also consider me too type of devices. They are very concerned with what I believe in patent parlance is " prior art." I read ETRM's patents and discussed this with the company. They said they pay very close attention to anything that even hints of infringement. Last year when the NY Times Magazine had that article on Hacking The Human Body I thought the others in the field were infringing. I still think that is the case but there has been no attempt to bring anything to market or before the FDA.
ETRM I believe is already working on the next generation which will be half the size of the existing issue. That is a matter of common sense as a smaller item will be in front of the FDA next year.
Hey moron read the SEC filing...Mulroy sold 114,000 shares at 11.70 and excercised 273,000 options at $1.71....He didn't buy anything..do the math genius
Fidelity..another 20,000 is an odd lot...N.B. Novavax has a ton of cash and is going to sell $175MM in stock..
Here they come.
...Drying up. Shorts can't find stock that is deliverable. The next news will be pretty good. They continue to do what they said they would. May 15th corporate update will be fascinating. There is a lot more going on than meets the eye. Be patient
Get ready pal. Bob is going to hit you with 15 million shares...You don't need luck with MACK.
The biotechs are fine if they are making money.
Nevada wants to pass a law regarding obesity. The Ultimate Fat Cat Law.
If you can't open it Google Obesity.
Where do you get this lunatic notion from? They do a reverse spilt and have no shares in float??
Get a life..You do not know what you are talking about. Another moron on IGNORE
Correct..I said in another post it is the same 100,000 shares a bunch of wise gys are tossing around trying to get you to sell. There is nothing going on at the company except trying to get VBLOC rolling and it is.
Corruption?? If there is corruption it is in the market that is trading this stock. If you have enough capital you can pretty much do what you want in a stock that trades at $1.00. Keep an eye out for a 13D. But don't accuse the company of corruption. It seems beneath you and anyone else even bringing that up. Nonsense. Ever hear of Sarbanes Oxley???? Do some research.
A lot of the expenses are paid to clinical trials and third parties. Getting a device through the FDA is terribly expensive. Ever see how much data is delivered to the FDA? Do not assume all the funds are paid to just the ETRM employees. They are still accumulating clinical data as the FDA mandated 5 years of data on existing implant patients. If I had to guess 50% of their expenses went to third parties.
We are spending a lot of time picking apart the people who run this company and they have a huge personal investment in the company. Why don't we just wait and see how the roll out goes and where we are in June.
I still believe there are people accumulating this stock who know a lot more about the roll out.imation The volume is decreasing and in my estimation smart money is buying as much stock as the can shake loose from anxious
owners who get frustrated. I think for instance that the same 100,000 shares is being tossed back and forth between a few players and market makers.
OK smart guy...tell me what you think is wrong and what the company is doing illegally or otherwise to have you make such a broad statement. I preface this question on one fact, "Did you at any time call the company and discuss this?" I have spoken to people and not their IR person who I think is useless. But other than what you read on this message board, what energized you to make the above comment?
Did you ever study basic finance? This is a new product. They have no idea about acceptance. Sure they could give the market a WAG but what if they miss???The bonus plan to me is great. It is all performance. Goal oriented.
Better than writing a check. The were awarded annual options and the have a great number from former years that are all under water and some have expired. You will get numbers from them when they themselves have a better idea. The device is 2 minths old. Come back in 6 months after you have read a rudimentary book on corporate finance.
Killed 111...Network biology may need a refit..No one is buying it and they have a lot fo 121 data...I do not have a position but have owned it for years. Ulrich leaving does not sit well with me. He seemed the brains behind the effort and Bob is a salesman. And I think the analysts are giving 398 too much revenue.
He is going to do a deal but a financing. If the biotechs stay under pressure he will raise money. He can't get a 121 deal done.